Epigallocatechin gallate attenuates tumor necrosis factor (TNF)-α-induced inhibition of osteoblastic differentiation by up-regulating lncRNA TUG1 in osteoporosis

References

• Gómez-Barrena E, Rosset P, Lozano D, et al. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015;70:93–101.
   PubMed Web of Science ®Google Scholar
• Kanis J, Johnell O, Gullberg B, et al. Risk factors for hip fracture in men from Southern Europe: the MEDOS study. Mediterranean osteoporosis study. Osteoporos Int. 1999;9(1):45–54.
   PubMed Web of Science ®Google Scholar
• Miller PD. Management of severe osteoporosis. Expert Opin Pharmacother. 2016;17(4):473–488.
   PubMed Web of Science ®Google Scholar
• Raehtz S, Bierhalter H, Schoenherr D, et al. Estrogen deficiency exacerbates type 1 diabetes-induced bone TNF-α expression and osteoporosis in female mice. Endocrinology. 2017;158(7):2086–2101.
   PubMed Web of Science ®Google Scholar
• Armas LA, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am. 2012;41(3):475–486.
   PubMed Web of Science ®Google Scholar
• Sleeman A, Clements JN. Abaloparatide: a new pharmacological option for osteoporosis. Am J Health Syst Pharm. 2019;76(3):130–135.
   PubMed Web of Science ®Google Scholar
• Muraki S, Yamamoto S, Ishibashi H, et al. Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci. 2007;12(4):317–320.
   PubMed Web of Science ®Google Scholar
• Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: the MEDOS study. Mediterranean osteoporosis study. J Bone Miner Res. 1995;10(11):1802–1815.
   PubMed Web of Science ®Google Scholar
• Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr. 2000;71(4):1003–1007.
   PubMed Web of Science ®Google Scholar
• Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem Rec. 2005;5(3):119–132.
   PubMed Web of Science ®Google Scholar
• Negri A, Naponelli V, Rizzi F, et al. Molecular targets of Epigallocatechin-Gallate (EGCG): a special focus on signal transduction and cancer. Nutrients. 2018;10(12):1936.
   PubMed Web of Science ®Google Scholar
• Lin SY, Kan JY, Lu CC, et al. Green tea catechin (-)-Epigallocatechin-3-Gallate (EGCG) facilitates fracture healing. Biomolecules. 2020;10(4):620.
   PubMed Web of Science ®Google Scholar
• Xi J, Li Q, Luo X, et al. Epigallocatechin‑3‑gallate protects against secondary osteoporosis in a mouse model via the Wnt/β‑catenin signaling pathway. Mol Med Rep. 2018;18(5):4555–4562.
   PubMed Web of Science ®Google Scholar
• Shen L, Wu C, Zhang J, et al. Roles and potential applications of lncRNAs in HIV infection. Int J Infect Dis. 2020;92:97–104.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, He S, et al. LncRNA MSC-AS1 promotes osteogenic differentiation and alleviates osteoporosis through sponging microRNA-140-5p to upregulate BMP2. Biochem Biophys Res Commun. 2019;519(4):790–796.
   PubMed Web of Science ®Google Scholar
• Fu Y, Hu X, Gao Y, et al. LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis. Bioengineered. 2021;12(1):7714–7723.
   PubMed Web of Science ®Google Scholar
• Li FP, Lin DQ, Gao LY. LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med Pharmacol Sci. 2018;22(21):7439–7447.
   PubMed Web of Science ®Google Scholar
• Liu SC, Sun QZ, Qiao XF, et al. LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(11):4584–4590.
   PubMed Web of Science ®Google Scholar
• Zhu WQ, Ming PP, Qiu J, et al. Effect of titanium ions on the Hippo/YAP signaling pathway in regulating biological behaviors of MC3T3-E1 osteoblasts. J Appl Toxicol. 2018;38(6):824–833.
   PubMed Web of Science ®Google Scholar
• Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 2000;141(11):3956–3964.
   PubMed Web of Science ®Google Scholar
• Amano S, Chang YT, Fukui Y. ERK5 activation is essential for osteoclast differentiation. PLoS One. 2015;10(4):e0125054.
   PubMed Web of Science ®Google Scholar
• Zhao L, Huang J, Zhang H, et al. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells. 2011;29(10):1601–1610.
   PubMed Web of Science ®Google Scholar
• Yu C, Li L, Xie F, et al. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2018;114(1):168–179.
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen Y, Zheng YJ, et al. LncRNA TUG1 promoted osteogenic differentiation through promoting bFGF ubiquitination. Vitro Cell Dev Biol Anim. 2020;56(1):42–48.
   PubMed Web of Science ®Google Scholar
• Shen CL, Yeh JK, Cao JJ, et al. Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats. Osteoporos Int. 2010;21(11):1841–1852.
   PubMed Web of Science ®Google Scholar
• Liu G, Zheng X, Xu Y, et al. Long non-coding RNAs expression profile in HepG2 cells reveals the potential role of long non-coding RNAs in the cholesterol metabolism. Chin Med J (Engl). 2015;128(1):91–97.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang P, Wang P, et al. EGCG enhances cisplatin sensitivity by regulating expression of the copper and cisplatin influx transporter CTR1 in ovary cancer. PLoS One. 2015;10(4):e0125402.
   PubMed Web of Science ®Google Scholar
• Oceandy D, Amanda B, Ashari FY, et al. The cross-talk between the TNF-α and RASSF-Hippo signalling pathways. Int J Mol Sci. 2019;20(9):2346.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li L, Gu W, et al. Resveratrol reverses osteogenic decline of bone marrow mesenchymal stem cells via upregulation of YAP expression in inflammatory environment. Stem Cells Dev. 2021;30(24):1202–1214.
   PubMed Web of Science ®Google Scholar
• Nie P, Li Y, Suo H, et al. Dasatinib promotes chondrogenic differentiation of human mesenchymal stem cells via the Src/Hippo-YAP signaling pathway. ACS Biomater Sci Eng. 2019;5(10):5255–5265.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Guo Y, Yu H, et al. Receptor activity-modifying protein 1 regulates the phenotypic expression of BMSCs via the Hippo/Yap pathway. J Cell Physiol. 2019;234(8):13969–13976.
   PubMed Web of Science ®Google Scholar
• Ma Y, Hu Y, Wu J, et al. Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes. Acta Biochim Biophys Sin (Shanghai). 2019;51(4):422–430.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang Y, Wang W, et al. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP. J Cell Biochem. 2018;119(12):9694–9706.
   PubMed Web of Science ®Google Scholar